Clinical trial / 2004
Vitamin E and beta-carotene supplementation had no overall effect on hospital-treated pneumonia risk in older male smokers.
In the ATBC study, 29,133 male smokers were randomized to receive vitamin E (50 mg/d), beta-carotene (20 mg/d), both, or placebo for a median of 6.1 years. Neither vitamin E (RR, 1.00; 95% CI, 0.88 to 1.14) nor beta-carotene (RR, 0.98; 95% CI, 0.85 to 1.11) had an overall effect on hospital-treated pneumonia incidence (898 total cases). However, in a post hoc subgroup of participants who started smoking at age 21 or older (n = 7,469; 196 cases), vitamin E decreased pneumonia risk (RR, 0.65; 95% CI, 0.49 to 0.86), while beta-carotene increased risk (RR, 1.42; 95% CI, 1.07 to 1.89).
- Study type
- Randomized, double-blind, placebo-controlled 2 x 2 factorial trial
- Who was studied
- 29,133 male smokers aged 50 to 69 years
- What was measured
- First occurrence of hospital-treated pneumonia
THE PAPER
Vitamin E and beta-carotene supplementation and hospital-treated pneumonia incidence in male smokers.
Hemilä H, Virtamo J, Albanes D, Kaprio J. Chest, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.